Atezolizumab TNBC indication ‘in jeopardy’ because of phase 3 resultsSeptember 9, 2020Breast CancerMetastatic Breast Cancer
First guideline on NGS testing in cancer, from ESMOAugust 28, 2020Breast CancerMetastatic Breast Cancer
Novel SERD, LSZ102, shows promise for pretreated ER+ breast cancerJune 30, 2020Breast CancerMetastatic Breast Cancer
Key Studies in Metastatic Breast Cancer From ASCO 2020June 22, 2020Breast CancerMetastatic Breast Cancer
‘A good and peaceful death’: Cancer hospice during the pandemicJune 5, 2020Breast CancerMetastatic Breast Cancer
TILs and PET-CT can predict pCR in HER2-positive metastatic breast cancerJune 2, 2020Breast CancerMetastatic Breast Cancer
Treating primary tumor doesn’t improve OS in stage IV breast cancerJune 1, 2020Breast CancerMetastatic Breast Cancer
Pyrotinib bests lapatinib in HER2+ metastatic breast cancerMay 31, 2020Breast CancerMetastatic Breast Cancer
Expanding the role of PARP inhibitors in breast cancerMay 31, 2020Breast CancerMetastatic Breast Cancer
Tucatinib improves PFS, OS in HER2+ breast cancer with brain metastasesMay 30, 2020Breast CancerMetastatic Breast Cancer
Pembrolizumab plus chemo shows benefits for PD-L1–rich triple-negative breast cancerMay 29, 2020Breast CancerMetastatic Breast Cancer
LOTUS: Ipatasertib plus paclitaxel may prolong OS in TNBCMay 28, 2020Breast CancerMetastatic Breast Cancer
Mammography cuts risk for fatal breast cancers: New dataMay 13, 2020Breast CancerMetastatic Breast Cancer
